Hotchkis & Wiley Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,018,300	Closed	-$147M	–	492
2022 Q1	$147M	Sell	2,018,300 -437,140	-18%	-$29.4M	0.47%	59
2021 Q4	$153M	Sell	2,455,440 -31,803	-1%	-$1.87M	0.48%	56
2021 Q3	$147M	Sell	2,487,243 -82,900	-3%	-$5.46M	0.47%	60
2021 Q2	$172M	Sell	2,570,143 -147,497	-5%	-$9.62M	0.52%	55
2021 Q1	$172M	Sell	2,717,640 -22,900	-0.8%	-$1.42M	0.52%	53
2020 Q4	$170M	Buy	+2,740,540	New	+$169M	0.59%	50

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Hotchkis & Wiley Capital Management's BMY Position: Q2 2022 in Review

Hotchkis & Wiley Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 2,018,300 shares — an estimated $147M sold.

Hotchkis & Wiley Capital Management first reported a position in BMY in Q4 2020 and held it in 6 quarters. The position peaked at $172M in Q2 2021. 2,540 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

Hotchkis & Wiley Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
Hotchkis & Wiley Capital Management sold 2,018,300 Bristol-Myers Squibb shares in Q2 2022, an estimated $147M.
Hotchkis & Wiley Capital Management first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 6 quarters.
Hotchkis & Wiley Capital Management's Bristol-Myers Squibb position peaked at $172M in Q2 2021.
2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.